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Introduction
Neural tube defects (NTDs) have an incidence of 1–2 per
1,000 births and are considered to be a heterogeneous
condition resulting from failure of normal neural tube
closure between the third and fourth week of embryonic
development. The three common types of NTDs are an-
encephaly, spina bifida, and encephalocele. The uncom-
mon types of NTDs include amniotic band syndrome,
limb–body wall complex, cloacal exstrophy or OEIS
complex, and other types of spinal abnormalities. The
incidence of NTDs varies with race, geographic variation,
socioeconomic classes, nutritional status, and multiple
predisposing factors such as single gene disorders,
chromosomal abnormalities, teratogens, maternal
diabetes, family history of NTDs, thermolabile mutation
in the MTHFR gene, and others [1]. There is considerable
evidence that genetics and environmental factors con-
tribute to the etiology of NTDs. Fetuses with NTDs may
be associated with syndromes, disorders, and maternal
risk factors.
Currarino Syndrome
Yates et al [2] first recognized the autosomal dominant
inheritance in Currarino syndrome. Currarino syn-
drome (OMIM 176450) or Currarino triad is charac-
terized by the triad of anorectal, sacral and presacral
anomalies: (1) a partial sacral agenesis with intact first
sacral vertebra; (2) a presacral mass such as anterior
meningocele, neuroenteric cyst, dermoid or epidermoid
cyst, lipoma, hamartoma, unclassified tumor, presacral
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teratoma or a combination of these; and (3) anorectal
malformations such as anorectal stenosis, imperforate
anus and anorectal sinus [3,4]. Other associated malfor-
mations include duplex ureters, horseshoe or duplex
kidneys, vesicoureteric reflux, secondary hydronephro-
sis, a bicornuate uterus, rectovaginal fistula, a septate
vagina, spinal cord tethering, and neuroenteric cysts [4].
In a study of 205 patients with Currarino syndrome,
Lynch et al [4] found asymptomatic subjects in 33% of
the cases, anterior meningocele in 50% of the cases, and
a presacral mass (teratoma, lipoma or cyst) in 42% of
the cases. Weinberg [5] suggested that the presacral
masses described as teratomas in Currarino syndrome
are actually hamartomas due to the absence of any
well-documented example of malignant germ cell tumor
associated with Currarino syndrome. The risk of malig-
nant transformation in the presacral teratomas of
Currarino syndrome is about 1%, which is much lower
than the risk of malignant transformation in sacrococ-
cygeal teratomas [4]. Ross et al [6] demonstrated 
the homeobox gene of HLXB9 (OMIM 142994) at
7q36 as the major locus for Currarino syndrome.
Hagan et al [7] identified mutations in the coding
sequence of HLXB9 in 95% (20/21) of cases of familial
Currarino syndrome and in approximately 30% (2/7)
of patients with sporadic Currarino syndrome. Remark-
able phenotypic variability and asymptomatic status in
half of the carriers have been observed in the family
members with mutations of the HLXB9 gene and
Currarino syndrome [8,9]. Identification of the HLXB9
gene mutation can confirm the diagnosis of Currarino
syndrome but cannot predict the severity of the 
disorder because of broad phenotypic variability in 
the expression of Currarino syndrome and lack of
genotype–phenotype correlation. Prenatal diagnosis of
Currarino syndrome by ultrasound is possible in preg-
nancy with a positive family history. Friedmann et al
[10] first described the prenatal diagnosis of Currarino
triad by the sonographic findings of a 1 cm cystic pre-
sacral mass in a 25-week gestation fetus whose mother
was known to have Currarino syndrome. Eliáš et al [11]
reported the prenatal sonographic diagnosis of Cur-
rarino triad in a 21-week gestation fetus with a sigmoid
kidney, a sacral bony defect, and low-lying medullary
conus. Magnetic resonance imaging (MRI) at 32 ges-
tational weeks revealed a rounded presacral, predomi-
nantly solid mass measuring about 1 cm and causing
spinal cord tethering. The mother was simultaneously
found to have Currarino triad by MRI. Crétolle et al [12]
reported the prenatal diagnosis of Currarino syndrome
in a 22-week gestation fetus with ventriculomegaly and
spinal dysraphism due to a c.584delA, p.H195fsX28
heterozygous frameshift HLXB9 mutation inherited from
the mother. The mother’s first pregnancy resulted in a
child with sickle-shaped sacrum associated with a low-
type anorectal malformation, a presacral teratoma, and
an intraspinal lipoma in line with the low-lying medullary
conus due to a maternally inherited pathogenic muta-
tion in the HLXB9 gene. The mother had a history of anal
atresia with cutaneous fistula, neonatal intestinal occlu-
sion, and a sickle-shaped sacrum. Because of the absence
of genotype–phenotype correlation and an extremely
high variability of phenotypes from typical triad to
undetectable minor sacral abnormalities in the carriers
of HLXB9 mutations, preimplantation genetic diagnosis
has been suggested as an important alternative for the
at-risk pregnancy [13]. Verlinsky et al [13] reported
the first preimplantation genetic diagnosis for the HLXB9
mutation in an at-risk couple. The couple had a previous
child with Currarino syndrome, imperforate anus,
anterior meningocele, and a sickle-shaped sacrum. The
husband had a mutation in the HLXB9 gene and a his-
tory of anal stricture and a sacral defect. One of his
two sisters had imperforate anus, anterior meningocele,
rectovaginal fistula, and a sacral defect, and the other
sister had anterior meningocele and no coccyx.
Sacral Defect with Anterior 
Meningocele (SDAM)
SDAM (OMIM 600145) is an autosomal dominant dis-
order. Fellous et al [14] reported a five-generation family
with sacral agenesis and spina bifida, and suggested
an autosomal dominant inheritance of the disease.
Chatkupt et al [15] reported autosomal dominant
SDAM in a five-generation family in which the family
members had hemisacral defects with or without anterior
meningocele. Gardner and Albright [16] reported hered-
itary anterior sacral meningocele and hemisacral defects
in a mother and her son. Both SDAM and Currarino triad
can be associated with the sacral defect and anterior
meningocele. Female patients with SDAM may experi-
ence obstructive labor because of anterior meningocele.
SDAM may be associated with mutations in the VANGL1
gene (OMIM 610132) on 1p13. Kibar et al [17] suggested
that mutations in the VANGL1 gene are associated with
NTDs in humans. Kibar et al [17] described a missense
mutation in the VANGL1 gene resulting in a substitution
of valine with isoleucine or V239I in a 10-year-old Italian
girl with caudal regression (type IV of sacral agenesis),
lipomyeloschisis, anorectal malformations, hydromelia,
and a tethered spinal cord. The girl’s mother and brother
carried the V239I mutation in the VANGL1 gene. The
mother showed no signs of NTDs, but the brother had
a mild NTD with dermal sinus.




Jarcho-Levin syndrome or spondylocostal dysostosis is
an autosomal recessive disorder. Spondylocostal dysos-
tosis is characterized by a shortened trunk, an opistho-
tonus position of the head, a short neck, a barrel-shaped
thorax, multiple wedge-shaped and block vertebrae,
spina bifida, and rib anomalies. Spina bifida is present
in 25% of patients [18]. Mutations in the genes that are
important components of the Notch signaling pathway
are responsible for the development of spondylocostal
dysostosis. Spondylocostal dysostosis, autosomal reces-
sive 1 (SCDO1; OMIM 277300) is caused by mutations
in the DLL3 gene (OMIM 602768) at 19q13; spondy-
locostal dysostosis, autosomal recessive 2 (SCDO2;
OMIM 608681) is caused by mutations in the MESP2
gene (OMIM 605195) at 15q26.1; and spondylocostal
dysostosis, autosomal recessive 3 (SCDO3; OMIM
609813) is caused by mutations in the LFNG gene (OMIM
602576) at 7p22. NTDs can be associated with segmen-
tal costovertebral malformations [19–28]. Reyes et al [19]
reported a case of Jarcho-Levin syndrome with diastem-
atomyelia of the thoracolumbar spinal cord and sug-
gested NTDs as a component of Jarcho-Levin syndrome.
Giacoia and Say [20] reported a patient with Jarcho-
Levin syndrome, spina bifida, and diastematomyelia,
and concluded that Jarcho-Levin syndrome and NTDs
are etiologically related. Rodriguez et al [21] reported
an infant with Jarcho-Levin syndrome, thoracolumbar
meningocele, imperforate anus, and perinatal death.
Duru et al [22] reported two patients with Jarcho-Levin
syndrome and NTDs, one of whom with lumbosacral
lipomyelomeningocele and the other with thoracolum-
bar myelomeningocele. Etus et al [23] reported a patient
with Jarcho-Levin syndrome, type I split cord malfor-
mation, and an accompanying spinal lipoma. Kauffmann
et al [24] reported the first-trimester prenatal diagnosis
of Jarcho-Levin syndrome in a fetus with sonographic
findings of a shortened spine, vertebral disorganization,
increased nuchal translucency thickness, spina bifida, and
renal calyces dilation at 13 gestational weeks. Nadkarni
et al [25] reported two patients with segmental costover-
tebral malformation and lumbosacral lipomyelomenin-
gocele. Yi et al [26] reported a case of Jarcho-Levin
syndrome with intrathoracic myelomeningocele. Dane
et al [27] reported the first-trimester prenatal diagnosis
of Jarcho-Levin syndrome in a fetus with sonographic
findings of a shortened spine, kyphoscoliosis, and spina
bifida at 13 gestational weeks. Dane et al [28] reported
four cases of Jarcho-Levin syndrome with NTDs as the
prominent prenatal diagnosis. Their first case had sono-
graphic findings of a vertebral disorganization, lumbosacral
spina bifida, bilateral talipes, and fixed extension of the
lower limbs at 24 gestational weeks. The second case had
sonographic findings of a vertebral disorganization, a
shortened spine, thoracolumbar spina bifida, hydro-
cephalus, skeletal kyphoscoliosis, and an asymmetric
short thorax at 24 gestational weeks. The third case had
sonographic findings of a vertebral disorganization,
thoracolumbar spina bifida, hydrocephalus, an asym-
metric thorax, a short truck, talipes, extension of the
lower limbs, and a prominent occiput at 22 gestational
weeks. The fourth case had sonographic findings of lum-
bosacral spina bifida, severe kyphosis, talipes, and fixed
extension of the lower limbs at 20 gestational weeks.
Prenatal diagnosis of vertebral deformities or spina bifida
should raise a suspicion of Jarcho-Levin syndrome
[29,30]. Fetuses with Jarcho-Levin syndrome may pres-
ent with increased nuchal translucency thickness on
prenatal ultrasound in the first trimester [31–33].
Lateral Meningocele Syndrome (LMS)
LMS (OMIM 130720) or Lehman syndrome is charac-
terized by multiple lateral meningoceles in the absence
of neurofibromatosis and Marfan syndrome. Other clin-
ical features of LMS include scoliosis, kyphosis, joint
hypermobility, pectus deformities, umbilical/inguinal
hernias, wormian bones, loose skin, and craniofacial
abnormalities such as ocular hypertelorism, downslant-
ing palpebral fissures, ptosis, low-set posteriorly rotated
ears, abnormal palate, molar hypoplasia and microg-
nathia, suggesting an underlying connective tissue dys-
plasia [34–38]. Lateral meningoceles are protrusions of
the arachnoid and the dura matter through inter- or
intravertebral foramina, and can present as widening of
the neural canal, thinning of the bony cortex of the ver-
tebral bodies and pedicles, dilation of the neural foram-
ina, and protrusion of dura outside the neural canal
[37]. LMS was first described in a 14-year-old girl with
generalized osteosclerosis, distinctive craniofacial fea-
tures, and multiple thoracic and lateral meningoceles
[34]. The mother was asymptomatic but had similar
craniofacial features. Gripp et al [37] suggested the term
“lateral meningocele syndrome”. Chen et al [38] suggested
that LMS is an autosomal dominant disorder, although
X-linked inheritance cannot be excluded because of
the absence of reported male-to-male transmission.
Neurofibromatosis Type I (NF1)
NF1 (OMIM 162200), characterized by café-au-lait
spots and fibromatous tumors of the skin, is caused by
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mutations in the neurofibromin gene (NF1) on chro-
mosome 17q11.2. NF1 is an autosomal dominant dis-
order. Meningoceles can be associated with NF1
especially in adults because of body defects of vertebral
scalloping, enlarged foramina, and deformed pedicles.
NF1 is seen in 63% of thoracic lateral meningoceles [39].
Nakasu et al [40] first reported computed tomography
(CT) and MRI findings of a thoracic meningocele in a
53-year-old female with NF1. Bensaid et al [41] reported
dural ectasia, a form of mild meningocele, and bilateral
symmetrical pedicular clefts in a 30-year-old female
and a 32-year-old female with NF1. Freund and Timon
[42] reported a 54-year-old female with NF1 and a
cervical meningocele presenting as a neck mass. Rainov
et al [43] described a 33-year-old female and a 53-
year-old male with NF1, ventrolateral thoracic and lum-
bar meningoceles, neurologic signs, and severe pain.
Miyata et al [44] reported resection of a right lumbar
lateral meningocele in a 29-year-old female with NF1.
Yoshioka et al [45] reported intracranial vascular mal-
formation and a meningocele in a 21-year-old male
with NF1. Kapadia et al [46] reported diffuse neurofi-
broma of the orbit and temporal meningocele in an 8-
year-old girl with NF1. de Vries et al [47] reported
successful surgical repair of progressive exophthalmos
caused by a protruding meningocele in a 43-year-old
female with NF1. Kurimoto et al [48] reported surgical
extirpations of a suboccipital meningocele presenting as
a huge retropharyngeal mass in a 73-year-old female with
NF1. Chapmann et al [49] reported an unusual ptery-
gopalatine meningocele in an 8-year-old boy associated
with NF1. Ogose et al [50] reported an intrathoracic
meningocele in a 42-year-old female with NF1. Mizuno
et al [51] reported a giant intrathoracic meningocele and
hydrothorax in a 67-year-old female with NF1. Ebara et al
[52] reported severe kyphoscoliosis and an intrathoracic
meningocele in a 59-year-old male with NF1. Reis et al
[53] reported epithelioid hemangioendothelioma and
multiple thoracolumbar lateral meningoceles in a 
31-year-old female with NF1.
Marfan Syndrome
Marfan syndrome (OMIM 154700) is a connective tis-
sue disorder with classical manifestations of aortic,
skeletal and ocular abnormalities. Marfan syndrome is
characterized by arachnodactyly with hyperextensibility,
pectus carinatum, pectus excavatum, scoliosis, spondy-
lolisthesis, pes planus, protrusio acetabuli, lens sublux-
ation, and aortic dilation. Marfan syndrome is caused
by mutations in the fibrillin-1 gene (OMIM 134797) on
chromosome 15q21.1 and has an autosomal dominant
inheritance pattern with wide variability in expression.
Dural ectasia is a common feature of Marfan syn-
drome. Pyeritz et al [54] reported that 63% (36/57) of
the patients with Marfan syndrome had widening of
the lumbosacral spinal canal and dural ectasia. Using
CT, Villeirs et al [55] assessed the widening of the spinal
canal and dural ectasia in Marfan syndrome. Using
MRI, Fattori et al [56] identified that 92% (76/83) of
the patients with Marfan syndrome had dural ectasia.
Dural ectasia is a ballooning or widening of the dural
sac and is often associated with herniation of the nerve
root sleeves out of the associated foramina [57]. Dural
ectasia may be associated with NF1, Marfan syndrome,
Ehlers-Danlos syndrome, and ankylosing spondylitis.
Ahn et al [57] suggested the criteria of dural ectasia on
MRI and CT images in adult Marfan patients. The major
criteria include: (1) width of dural sac below L5 >
width below L4, and (2) anterior sacral meningocele.
The minor criteria include: (1) L5 nerve root sleeve
diameter > 6.5 mm, and (2) S1 scalloping > 3.5. Dural
ectasia exists if one major or two minor criteria are
present. Strand and Eisenberg [58] reported anterior
sacral meningocele in association with Marfan syndrome
in a 10-year-old boy. Harkens and el-Khoury [59]
reported intrasacral meningocele in a 54-year-old male
with Marfan syndrome. Raftopoulos et al [60] described
a huge bilobed complex sacral meningocele cured
endoscopically in a 33-year-old female with Marfan
syndrome. Schneider et al [61] reported anterior sacral
meningocele presenting as a pelvic/abdominal mass in
a 25-year-old female with Marfan syndrome. Voyvodic
et al [62] reported two Marfan females with anterior
sacral meningoceles presenting as non-gynecologic
pelvic masses. The presence of dural ectasia is associated
with back pain in more than 50% of patients with
Marfan syndrome; however, dural ectasia was noted to
exist in 41% of patients with Marfan syndrome without
back pain [63]. Rigante and Segni [64] reported ante-
rior sacral meningocele in an 18-year-old male with
Marfan syndrome. Nallamshetty et al [65] reported a
significantly large anterior sacral meningocele in a 
52-year-old female without associated symptoms.
Hyperthermia
In humans, an oral temperature of 37°C or a deep body
(core) temperature of 38°C is considered normal [66].
A 2°C elevation of maternal temperature to 39°C in
oral temperature or to 40°C in core temperature is
regarded as the threshold of damage [67]. In humans,
a body temperature above the upper limit of the normal
range has been associated with NTDs [68–83]. In a
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comparative study involving 23,491 women of hyper-
thermic exposure limited to hot tub, sauna, fever or
electric blanket in New England, Milunsky et al [78]
found that exposure to heat in the form of hot tub,
sauna or fever in the first trimester of pregnancy was
associated with an increased risk for NTDs. The relative
risks (RRs) were 2.8 (95% confidence interval, CI,
1.2–6.5) for hot tub use, 1.8 (95% CI, 0.4–7.9) for sauna,
1.8 (95% CI, 0.8–4.1) for fever, and 1.2 (95% CI,
0.5–2.6) for electric blanket; and when only hot tub
use, sauna and fever were considered, the RR for NTDs
increased from 1.9 (95% CI, 0.9–3.7) after one type 
of heat exposure to 6.2 (95% CI, 2.2–17.2) after two
types of exposure [78]. In a comparative study involving
538 NTD cases and 538 non-malformed controls in
California, Shaw et al [81] found that a maternal fever
or febrile illness episode in the first trimester was associ-
ated with an increased risk for having an NTD-affected
pregnancy with an odds ratio (OR) of 1.91 (90% CI,
1.35–2.72) for fever and an OR of 2.02 (95% CI,
1.20–3.43) for febrile illness. In a comparative study
involving 175 NTD cases and 221 controls in a Texas-
Mexico border population, Suarez et al [83] found that
maternal hyperthermia was associated with an increased
risk of NTDs. The RR was 3.6 (95% CI, 1.1–15.9) for first-
trimester maternal exposures to heat devices such as
hot tubs, saunas or electric blankets, and small insignif-
icant effects were observed for cooking in a hot kitchen
(OR, 1.6; 95% CI, 1.0–2.6) and working or exercising
in the sun (OR, 1.4; 95% CI, 0.9–2.2). In a meta-analysis
of 15 studies from 1966 to 2003 that included 1,719
NTD cases and 37,898 non-cases, Moretti et al [84]
found that the overall OR for NTDs associated with
maternal hyperthermia was 1.92 (95% CI, 1.61–2.29),
and concluded that maternal hyperthermia in early
pregnancy is associated with an increased risk for NTDs
and may be a human teratogen. The Centers for Disease
Control and Prevention [85] suggested that women of
reproductive age should take 400 µg of supplemental
folic acid daily to reduce the risk of NTDs. Medveczky
et al [86] concluded that maternal fever is a possible
cause of NTDs, and maternal fever during pregnancy
should be treated with antipyretics. Chambers [87] sug-
gested that women of reproductive age should also be
aware of the possible variability in hot tub or spa temper-
ature reading, and be able to accurately monitor maxi-
mum water temperature in the hot tub or spa to reduce
the risk of NTDs. Harvey et al [88] suggested limits for
the use of hot tub and sauna by pregnant women to less
than 15 min in 39°C water and to less than 10 min in
40°C water. The recommended time should be reduced
if there exist other risk factors such as poor health,
fever, exercise or any source of hyperthermia [87].
Susceptibility to hyperthermia-induced NTDs appears
to be associated with an embryonic effect through ele-
vation of the maternal core temperature [89], a dose-
response of temperature and duration of exposure [90],
and a genetic basis [91,92]. In a study of the effect of
hyperthermia on rat embryos in culture by completely
removing the embryo from maternal influence and expos-
ing rat embryonic explants to mild hyperthermic insult
during the onset of neural tube closure, Cockroft and
New [89] found that nearly one-half of the exposed rat
embryos were microcephalic. In a study of the param-
eters determining hyperthermia-induced head defects
in the rat, Germain et al [90] found a dose-response
manner of temperature and duration of exposure in the
induction of NTDs in the experimental animals. Finnell
et al [91,92] hypothesized that subtle genetic changes
can result in NTDs by the findings of strain-dependent
differences in susceptibility to teratogenic insults and
altered patterns of gene expression observed within
the neuroepithelium of the affected embryos. Lundberg
et al [93] reported the first genetic dissection of mater-
nal hyperthermia-induced NTD in mice and demon-
strated that a single fetal genetic locus and a maternal
effect can cause the strain differences in the susceptibil-
ity to hyperthermia-induced exencephaly. Yang et al [94]
recently identified the differentially expressed genes that
participate in the pathologic course of hyperthermia-
induced NTDs in golden hamsters using suppression
subtractive hybridization.
Conclusion
This article provides a comprehensive review of syn-
dromes, disorders, and maternal risk factors associated
with NTDs, such as Currarino syndrome, SDAM, Jarcho-
Levin syndrome (spondylocostal dysostosis), LMS, NF1,
Marfan syndrome and hyperthermia. NTDs associated
with syndromes, disorders, and maternal risk factors are
a rare but important cause of NTDs. The recurrence risk
and the preventive effect of maternal folic acid intake in
NTDs associated with syndromes, disorders, and mater-
nal risk factors may be different from those of non-syn-
dromic multifactorial NTDs. Perinatal identification of
NTDs should alert one to the syndromes, disorders, and
maternal risk factors associated with NTDs, and prompt a
thorough etiologic investigation and genetic counseling.
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